Boston Scientific (BSX) Job Cuts on the Way
Tweet Send to a FriendGet Alerts BSX Hot Sheet
Trade BSX Now!
Boston Scientific (NYSE: BSX) is preparing to make another round of job cuts, according to reports. Amid management changes, the company has had a difficult time maintaining revenue growth this year, and despite improvements in margins the stock has underperformed.
Boston Scientific will also separate its cardiac rhythm management (CRM) unit, which makes heart pacemakers and defibrillators, from its interventional cardiology business, which makes stents. Total CRM sales totaled $488 million in the second quarter and were down 10 percent. The performance reflected declines and weaker results in both ICDs and pacemakers. Performance in this area is expected to be lackluster for most of 2012, say analysts. Second quarter sales of coronary stents declined by 21 from the prior year, totaled only $340 million from 428 in the previous year.
The job cuts confirm an announcement in a letter to employees and are related to manufacturing adjustments and not related to the separation of its CRM unit. The exact number of cuts is unknown at this time, but a formal announcement is expected within the next few months.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Boston Scientific will also separate its cardiac rhythm management (CRM) unit, which makes heart pacemakers and defibrillators, from its interventional cardiology business, which makes stents. Total CRM sales totaled $488 million in the second quarter and were down 10 percent. The performance reflected declines and weaker results in both ICDs and pacemakers. Performance in this area is expected to be lackluster for most of 2012, say analysts. Second quarter sales of coronary stents declined by 21 from the prior year, totaled only $340 million from 428 in the previous year.
The job cuts confirm an announcement in a letter to employees and are related to manufacturing adjustments and not related to the separation of its CRM unit. The exact number of cuts is unknown at this time, but a formal announcement is expected within the next few months.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Senate Takes Aim at Apple (AAPL); Says Irish Unit Earned $22B, Paid $10M in Taxes
- Elan Corp (ELN) Plans Strategic Change of Company; Proposes $200M Buyback
- Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Layoffs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
